{"disease":{"id":"locally-advanced-or-metastatic-urothelial-carcinoma-uc-with-disease-progression-during-or-following-platinum-containing-chemotherapy-or-within-12-months-of-receiving-neoadjuvant-or-adjuvant-platinum-containing-chemotherapy-in-patients-who-are-not-eligible-for-platinum-containing-chemotherapy-and-have-a-pd-l1-combined-positive-score-cps-10-as-determined-by-an-fda-approved-test-in-combination-with-pembrolizumab-and-lenvatinib-in-patients-with-a-pd-l1-cps-10-as-determined-by-an-fda-approved-test","name":"locally advanced or metastatic urothelial carcinoma uc with disease progression during or following platinum containing chemotherapy or within 12 months of receiving neoadjuvant or adjuvant platinum containing chemotherapy in patients who are not eligible for platinum containing chemotherapy and have a pd l1 combined positive score cps 10 as determined by an fda approved test in combination with pembrolizumab and lenvatinib in patients with a pd l1 cps 10 as determined by an fda approved test"},"drugs":{"marketed":[{"drug_id":"pf-06823859","indication_name":"Locally Advanced or Metastatic Urothelial Carcinoma (UC) with disease progression during or following platinum-containing chemotherapy or within 12 months of receiving neoadjuvant or adjuvant platinum-containing chemotherapy in patients who are not eligible for platinum-containing chemotherapy and have a PD-L1 combined positive score (CPS) ≥ 10 as determined by an FDA-approved test in combination with pembrolizumab and lenvatinib in patients with a PD-L1 CPS ≥ 10 as determined by an FDA-approved test.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pf-06823859","generic_name":"pf-06823859","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"PD-1/PD-L1","drug_class":"Monoclonal Antibody","quality_score":10,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}